Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1997-03-25
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 530380, 530385, 424529, 424530, 424533, A61K 3816
Patent
active
056144903
ABSTRACT:
This invention provides a method to therapeutically increase perfusion in a mammal comprising administering stroma-free hemoglobin at a dose ranging from the least amount effective to increase perfusion, up to a dose of about 2500 mg per kilogram of body weight.
REFERENCES:
patent: 3991181 (1976-11-01), Doczi
patent: 4529719 (1985-07-01), Tye
patent: 4532130 (1985-07-01), Djordjevich et al.
patent: 4988515 (1991-01-01), Buckberg
patent: 5296466 (1994-03-01), Kilbourn et al.
Parrat et al, Applied Cardiopuluronary Pathophysiology, vol. 4, pp. 143-149, 1991.
Kilbourn et al, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 3629-3632, May 1990.
Kilbourn et al, Biochemical and Biophysical Research Communications, vol. 172, No. 3, pp. 1132-1138, Nov. 15, 1990.
Kosaha et al, Free Radical Biology & Medicine, vol. 7, pp. 653-658, 1989.
Buga et al, European Journal of Pharmacology, vol. 161, pp. 61-72, 1989.
Martin et al, The Journal of Pharmacology and Experimental Therapeutics, vol. 232, No. 3, pp. 708-716, 1985.
G. P. Biro, et al, "Coronary Vascular Actions of Stroma-Free Hemoglobin Preparations", Artificial Organs, vol. 12, No. 1, 1988, pp. 40-50.
Robert F. Wilson, et al., "The use of arterial-central venous oxygen differences to calculate cardiac output and oxygen consumption in critically ill surgical patients", Surgery, vol. 84, No. 3, Sep. 1978, pp. 361-369.
S. A. Levinson, et al, "Effect of Exchange Transfusion with Fresh Whole Blood on Refractory Septic Shock" The American Surgeon, Jan. 1972, pp. 49-55.
C. J. Hauser, et al., "Hemoglobin solution in the treatment of hemorrhagic shock" Critical Care Medicine, vol. 10, No. 4, Apr. 1982, pp. 283-287.
John E. Nees, et al "Comparison of cardiorespiratory effects of crystalline hemoglobin, whole blood, albumin, and Ringer's lactate in the resuscitation of hemorrhagic shock in dogs", Surgery, vol. 83, No. 6, Jun. 1978, pp. 639-647.
William Martin, et al, "Selective Blockade of Endothelium-Dependent and Glyceryl Trinitrate-Induced Relaxation by Hemoglobin and by Methylene Blue in the Rabbit Aorta", The Journal of Pharmacology and Experimental Therapeutics, vol. 232, No. 3, pp. 708-715, 1985.
Anne Bowman, et al, "Actions on the Cardiovascular System of an Inhibitory Material Extracted from the Bovine Retractor Penis", Br. J. Pharmac. (1981) 72, 365-372.
D. J. Stewart, et al. "The Role of Endothelium-derived Relaxing Factor (EDRF) in the Acetylcholine-induced Dilation of Coronary Resistance Vessels", Abstract No. 81 (1987).
U. Pohl, et al, "Endothelium-dependent modulation of vascular tone and platelet function" European Heart Journal (1990), 11, 35-42.
John S. Gillespie et al, "A comparison of haemoglobin and erythrocytes as inhibitors of smooth muscle relaxation by the NANC transmitter in the BRP and rat anococcygeus and by EDRF in the rabbit aortic strip", Br. J. Pharmacol., (1989), 98, 445-450.
U. Pohl, et al, "EDRF Increases Cyclic GMP in Platelets Passage Through the Coronary Vascular Bed", Circulation Research, vol. 65, No. 6, Dec. 1989.
Robert F. Furchgott, "Studies on Relaxation of Rabbit Aorta by Sodium Nitrite: The Basis for the Proposal that the Acid-Activatable Inhibitory Factor from Bovine Retractor Penis is Inorganic Nitrite and the Endothelium-derived Relatxing Factor is Nitric Oxide", Vasodilation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium; 4th International Symposium on Mechanism of Vasodilation, Rochester, Minnesota, Jul. 10-12, 1986, Raven Press Ltd. New York, N.Y.
Ulrich Pohl, et al "EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries", Journal of Physiology, 261, (6):H2016-H2023 (1991).
Ulrich Pohl, et al "Hypoxia stimulates release of endothelium-derived relaxant factor", Am. J. Physiol. 256, 6 Part 2, 1989, H1595-H1600.
Carl A. Gruetter, et al, "Coronary Arterial Relaxation and Guanylate Cyclase Activation by Cigarette Smoke N'-Nitrosonornicotine and Nitric Oxide", J. of Pharmacology and Experimental Therapeutics, vol. 214, No. 1, pp. 9-15, 1980.
Amberson, W. R. et al., "On Use of Ringer-Locke Solutions Containing Hemoglobin as a Substitute for Normal Blood in Mammals," J Cell Comp Physiol, 5:359 (1934).
Amberson, W. R. et al., "Clinical Experienced with Hemoglobin-Saline Solutions" J Appl Physiol, 1:469 (1949).
Birndorf, N. I. Et al., : "Effect of Red Cell Stroma-Free hemoglobin Solution on Renal Function in Monkeys" J Appl Physiol, 29:573 (1970).
Biro, G.P. et al., "The Effect of Hemodilution with Stroma-Free Hemoglobin and Dextran on Collateral Perfusion of Ischemic Myocardium in the Dog" Am Hrt J, 99:64 (1980).
Buttle, G. A. H. et al., "Blood Substitutes in Treatment of Acute Hemorrhage" Lancet, 2:507 (1940).
Elia, E. et al., "Stroma-Free hemoglobin in the Resuscitation of Hemorrhagic Shock" Surg Forum, 25:201 (1974).
Feola, M. et al., "Improved Oxygenation of Ischemic Myocardium by Hemodilution with Stroma-Free Hemoglobin Solution" Chest, 75:369 (1979).
Feola, M. et al., "Toxicity of Polymerized Hemoglobin Solutions" Surg Gynecol Obstet, 166:211 (1988).
Jan, K. M. et al, "Coronary Hemodynamics and Oxygen Utilization after hematocrit Variations in Hemorrhage" am J Physiol, 239:H326 (1980).
Jesch, F. H. et al., "Oxygen-Transporting Fluids and Oxygen Delivery with Hemodilution" Crit Care Med, 10:270 (1982).
Keipert, P. E. et al ., "Pyridoxylated Polyhemoglobin as a Red cell substitute for Resuscitation of Lethal Hemorrhagic Shock in Conscious Rats" Biomater Med Devices Artif Organs, 13:1 (1985).
Maningas, P. A. et al., "Hypertonic Sodium Chloride Solutions for the Prehospital management of Traumatic Hemorrhagic Shock: A Possible Improvement in the Standard of Care?" Ann Emerg Med, 15:1411 (1986).
Miller, J. H. et al., "The Effect of Hemoglobin in Renal Function in the Human" J. Clin Invest, 30:1033 (1951).
Moss, G. S. et al., "Transport of Oxygen and Carbon Dioxide by Hemoglobin-Saline Solution in the Red Cell Free Primate" Surg Genecol Obstet, 142:357 (1976).
Peskin, W. P. et al., "Stroma-Free Hemoglobin Solution: The `Ideal` Blood Substitute?" Surgery, 66:185 (1969).
Prough, D. S. et al., "Effects of Hypertonic Saline Versus Lactated Ringer's Solution on Cerebral Oxygen Transport During Resuscitation from Hemorrhagic Shock" J. Neurosurg, 64:627 (1986).
Przybelski, R.J. et al., J Lab and Clin Med, 117:143 to 151 (1991).
Rabiner, S.F. et al., J Exp Med, 126:1127 to 1142 (1967).
Rabiner, S.F., "Hemoglobin Solution as a Plasma Expander" Fed Proc, 34:1454 (1975).
Shoemarker, W.C. et al., "Resuscitation of the Trauma Patient; Resotration of Hemodynamic Functions Using Clinical Algorithms" Ann Emerg Med, 15:1437 (1986).
Wade, C.E. et al., "Superiority of Hypertonic Saline/Dextran over Hypertonic Saline During the First 30 Minutes of Resuscitation Following Hemorrhagic Hypotension in Conscious Swine" Resuscitation, 20:49 (1990).
Relihan, M. Et al., "Clearance Rate and Effect on Renal Function of Stroma-Free Hemoglobin Following Renal Ischemic" Ann Surg, 176:700 (1972).
Savitsky, J.P. et al., "A Clinical Safety Trial of Stroma-Free Hemoglobin" Clin Phamacol ther, 23:73 (1978).
Baxter Healthcare Corporation
Sayala Chhaya D.
LandOfFree
Administration of low dose hemoglobin to increase perfusion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of low dose hemoglobin to increase perfusion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of low dose hemoglobin to increase perfusion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203403